FOPH evaluations of drugs on the specialities list

Since 1 June 2015 the FOPH has published background information on its evaluation of drugs for the specialities list.

Pursuant to Art. 71 Para 2 of the Health Insurance Ordinance of 27 June 1995 (KVV/OAMal; SR 832.102) the FOPH has published back-ground information on the evaluation of the efficacy and expediency of drugs, price comparisons with different drugs, and innovation surcharges when new original formulations are added to the specialities list, indications are extended and limitations are amended.

You will find all new admissions and changes of limitations made since 1 June 2015 under ‘Documents’ (in german only).

Documents

Admissions and changes of limitations made since 1 April 2019

Admissions and changes of limitations made since 1 March 2019

Admissions and changes of limitations made since 1 February 2019

Admissions and changes of limitations made since 1 January 2019

Admissions and changes of limitations made since 1 November 2018

Admissions and changes of limitations made since 1 September 2018

Admissions and changes of limitations made since 1 August 2018

Admissions and changes of limitations made since 1 July 2018

Admissions and changes of limitations made since 1 June 2018

Admissions and changes of limitations made since 1 May 2018

Admissions and changes of limitations made since 1 April 2018

Admissions and changes of limitations made since 1 March 2018

Admissions and changes of limitations made since 1 February 2018

Admissions and changes of limitations made since 1 January 2018

Admissions and changes of limitations made since 1 December 2017

Admissions and changes of limitations made since 1 November 2017

Admissions and changes of limitations made since 1 October 2017

Admissions and changes of limitations made since 1 September 2017

Admissions and changes of limitations made since 1 August 2017

Admissions and changes of limitations made since 1 July 2017

Admissions and changes of limitations made since 1 June 2017

Admissions and changes of limitations made since 1 May 2017

Admissions and changes of limitations made since 1 April 2017

Admissions and changes of limitations made since 1 March 2017

Admissions and changes of limitations made since 1 February 2017

Admissions and changes of limitations made since 1 January 2017

Admissions and changes of limitations made since 1 December 2016

Admissions and changes of limitations made since 1 November 2016


Admissions and changes of limitations made since 1 October 2016

Admissions and changes of limitations made since 1 September 2016

Admissions and changes of limitations made since 1 August 2016

Admissions and changes of limitations made since 1 July 2016

Admissions and changes of limitations made since 1 June 2016

Admissions and changes of limitations made since 1 May 2016

Admissions and changes of limitations made since 1 April 2016

Admissions and changes of limitations made since 1 March 2016

Admissions and changes of limitations made since 1 February 2016

Admissions and changes of limitations made since 1 January 2016

Admissions and changes of limitations made since 1 December 2015

Admissions and changes of limitations made since 1 November 2015

Admissions and changes of limitations made since 1 October 2015

Admissions and changes of limitations made since 1 September 2015

Admissions and changes of limitations made since 1 August 2015

Admissions and changes of limitations made since 1 July 2015

Last modification 07.10.2019

Top of page

Contact

Federal Office of Public Health FOPH
Health and Accident Insurance Directorate
Authorisation of Pharmaceuticals
Schwarzenburgstrasse 157
3003 Bern
Tel. +41 58 462 90 35
E-mail

Print contact

https://www.bag.admin.ch/content/bag/en/home/versicherungen/krankenversicherung/krankenversicherung-leistungen-tarife/Arzneimittel/Beurteilungen-BAG-von-Arzneimitteln-der-Spezialitaetenliste.html